Publicacions (106) Publicacions de Laura Senovilla Gonzalez

2024

  1. Obesity-Associated Colorectal Cancer

    International Journal of Molecular Sciences, Vol. 25, Núm. 16

2023

  1. Involvement of Bcl-2 Family Proteins in Tetraploidization-Related Senescence

    International Journal of Molecular Sciences, Vol. 24, Núm. 7

  2. Multiomics insights on the onset, progression, and metastatic evolution of breast cancer

    Frontiers in Oncology, Vol. 13

2022

  1. ACBP/DBI protein neutralization confers autophagy-dependent organ protection through inhibition of cell loss, inflammation, and fibrosis

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 41

2021

  1. Clonogenic Assays to Detect Cell Fate in Mitotic Catastrophe

    Methods in Molecular Biology (Humana Press Inc.), pp. 227-239

  2. Everolimus and plicamycin specifically target chemoresistant colorectal cancer cells of the CMS4 subtype

    Cell Death and Disease, Vol. 12, Núm. 11

  3. In Vivo Imaging of Orthotopic Lung Cancer Models in Mice

    Methods in Molecular Biology (Humana Press Inc.), pp. 199-212

  4. Paradoxical implication of BAX/BAK in the persistence of tetraploid cells

    Cell Death and Disease, Vol. 12, Núm. 11

  5. Quantification of eIF2α Phosphorylation Associated with Mitotic Catastrophe by Immunofluorescence Microscopy

    Methods in Molecular Biology (Humana Press Inc.), pp. 217-226

2020

  1. Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

    Nature Communications, Vol. 11, Núm. 1

  2. Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer (Nature Communications, (2020), 11, 1, (3819), 10.1038/s41467-020-17644-0)

    Nature Communications

2019

  1. Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer (Nature Communications, (2019), 10, 1, (1486), 10.1038/s41467-019-09415-3)

    Nature Communications

  2. Crizotinib-induced immunogenic cell death in non-small cell lung cancer

    Nature Communications, Vol. 10, Núm. 1

  3. Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity

    OncoImmunology, Vol. 8, Núm. 11

  4. Suppression of tumor antigen presentation during aneuploid tumor evolution contributes to immune evasion

    OncoImmunology, Vol. 8, Núm. 11

2018

  1. Calcium signaling and cell cycle: Progression or death

    Cell Calcium, Vol. 70, pp. 3-15

  2. Immune effectors responsible for the elimination of hyperploid cancer cells

    OncoImmunology, Vol. 7, Núm. 8

  3. eIF2α phosphorylation is pathognomonic for immunogenic cell death

    Cell Death and Differentiation, Vol. 25, Núm. 8, pp. 1375-1393

2017

  1. Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance

    Immunological Reviews, Vol. 280, Núm. 1, pp. 165-174

2016

  1. Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate

    OncoImmunology, Vol. 5, Núm. 6